257 related articles for article (PubMed ID: 26826415)
21. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
22. An approach to malignant mammary phyllodes tumors detection.
Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
[TBL] [Abstract][Full Text] [Related]
23. The Utility of Phosphohistone H3 in Breast Cancer Grading.
Cui X; Harada S; Shen D; Siegal GP; Wei S
Appl Immunohistochem Mol Morphol; 2015; 23(10):689-95. PubMed ID: 25611243
[TBL] [Abstract][Full Text] [Related]
24. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
Gunia S; Kakies C; Erbersdobler A; Koch S; May M
J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964
[TBL] [Abstract][Full Text] [Related]
25. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
26. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal Stromal Tumors Risk Stratification Utilizing Phospho-Histone H3 Evaluated by Manual Counting and Computer-Assisted Image Analysis.
Jin C; Huang Y; Nasim M; Yang Y; Lee L
Int J Surg Pathol; 2019 Oct; 27(7):706-712. PubMed ID: 31146625
[No Abstract] [Full Text] [Related]
28. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
Kim YJ; Ketter R; Steudel WI; Feiden W
Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
[TBL] [Abstract][Full Text] [Related]
29. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
30. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
[TBL] [Abstract][Full Text] [Related]
31. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
[TBL] [Abstract][Full Text] [Related]
32. Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.
Mirzaiian E; Tabatabaei Ghods ZS; Tavangar SM; Emami B; Oraie M; Safyari R; Saffar H
Asian Pac J Cancer Prev; 2020 Jan; 21(1):63-66. PubMed ID: 31983165
[TBL] [Abstract][Full Text] [Related]
33. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M
Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531
[TBL] [Abstract][Full Text] [Related]
34. PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors.
Shin Y; Hyeon J; Lee B; Ha SY; Hong ME; Do IG; Kim KM
J Pathol Transl Med; 2015 Jan; 49(1):23-9. PubMed ID: 25812654
[TBL] [Abstract][Full Text] [Related]
35. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count.
Khieu ML; Broadwater DR; Aden JK; Coviello JM; Lynch DT; Hall JM
Am J Clin Pathol; 2019 May; 151(6):542-550. PubMed ID: 30788495
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
[TBL] [Abstract][Full Text] [Related]
37. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.
Draganova-Tacheva R; Bibbo M; Birbe R; Daskalakis C; Solomides C
Acta Cytol; 2013; 57(3):291-5. PubMed ID: 23635399
[TBL] [Abstract][Full Text] [Related]
38. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
39. Nottingham-defined mitotic score: comparison with visual and image cytometric phosphohistone H3 labeling indices and correlation with Oncotype DX recurrence score.
Zbytek B; Cohen C; Wang J; Page A; Williams DJ; Adams AL
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):48-53. PubMed ID: 22495373
[TBL] [Abstract][Full Text] [Related]
40. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
